Generation of a Monoclonal Antibody Agonist to Toll-Like Receptor 4
Author:
Affiliation:
1. Genomics Institute of the Novartis Research Foundation, San Diego, California.
Publisher
Mary Ann Liebert Inc
Subject
Immunology,Immunology and Allergy
Link
http://www.liebertpub.com/doi/pdf/10.1089/hyb.2005.24.27
Reference41 articles.
1. Inferences, questions and possibilities in Toll-like receptor signalling
2. Gram‐negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction 1
3. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
4. Regulatory Roles for CD14 and Phosphatidylinositol in the Signaling via Toll-like Receptor 4-MD-2
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma;Veterinary Immunology and Immunopathology;2015-04
2. Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery;Science;2011-12-09
3. Accelerated Prion Disease Pathogenesis in Toll-Like Receptor 4 Signaling-Mutant Mice;Journal of Virology;2008-11
4. Pivotal Involvement of Fcγ Receptor IIA in the Neutralization of Lipopolysaccharide Signaling via a Potent Novel Anti-TLR4 Monoclonal Antibody 15C1;Journal of Biological Chemistry;2007-11
5. Induction of Long-Term Lipopolysaccharide Tolerance by an Agonistic Monoclonal Antibody to the Toll-Like Receptor 4/MD-2 Complex;Clinical and Vaccine Immunology;2006-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3